Home/Filings/4/0001209191-20-026844
4//SEC Filing

Haag-Molkenteller Cornelia 4

Accession 0001209191-20-026844

CIK 0001740547other

Filed

May 3, 8:00 PM ET

Accepted

May 4, 4:57 PM ET

Size

4.9 KB

Accession

0001209191-20-026844

Insider Transaction Report

Form 4
Period: 2020-05-01
Haag-Molkenteller Cornelia
CMO of Urovant Sciences, Inc.
Transactions
  • Award

    Common Shares

    2020-05-01+83,149145,277 total
Footnotes (1)
  • [F1]25% of the Restricted Stock Units shall vest on May 1, 2021; the remaining Restricted Stock Units vest in 12 equal quarterly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer through each such vesting date.

Issuer

Urovant Sciences Ltd.

CIK 0001740547

Entity typeother

Related Parties

1
  • filerCIK 0001748297

Filing Metadata

Form type
4
Filed
May 3, 8:00 PM ET
Accepted
May 4, 4:57 PM ET
Size
4.9 KB